Jae‐Sook Ahn

Nilotinib combined with multiagent chemotherapy for newly diagnosed Philadelphia-positive acute lymphoblastic leukemia

Dae‐Young Kim, Young‐Don Joo, Sung-Nam Lim et al. · Blood · 2015 · 184 citations · Full text

Medicine, Oncology, Pharmacology +11

Prognostic factors in primary diffuse large B-cell lymphoma of adrenal gland treated with rituximab-CHOP chemotherapy from the Consortium for Improving Survival of Lymphoma (CISL)

Yu Ri Kim, Jin Seok Kim, Yoo Hong Min et al. · Journal of Hematology & Oncology · 2012 · 97 citations · Full text

Medicine, Oncology, Chemotherapy +10

Prognostic significance of interim 18F-FDG PET/CT after three or four cycles of R-CHOP chemotherapy in the treatment of diffuse large B-cell lymphoma

Deok‐Hwan Yang, Jung‐Joon Min, Ho‐Chun Song et al. · European Journal of Cancer · 2011 · 88 citations

Medicine, Oncology, Chemotherapy +8

Interim PET/CT-based prognostic model for the treatment of diffuse large B cell lymphoma in the post-rituximab era

Deok‐Hwan Yang, Jae‐Sook Ahn, Byung Hyun Byun et al. · Annals of Hematology · 2012 · 76 citations

Medicine, Hematology, Oncology +14

Endothelial activation and stress index (EASIX) is a reliable predictor for overall survival in patients with multiple myeloma

Ga‐Young Song, Sung‐Hoon Jung, Seok Jin Kim et al. · BMC Cancer · 2020 · 72 citations · Full text

Veterinary Medicine, Immunology, Oncology +15